Moderna agrees to true placebo-controlled trial of new COVID vaccine, Kennedy says
1. Moderna will conduct a true placebo-controlled trial for its new COVID-19 vaccine.
FAQ
Why Bullish?
Conducting a placebo-controlled trial may strengthen MRNA's credibility, reminiscent of previous successful trials boosting stock prices.
How important is it?
The trial's success could enhance Moderna's market position and stock performance.
Why Short Term?
Results from the trial could affect MRNA's stock in the upcoming quarters, similar to past vaccine trials.